Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/2170
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Andrieieva, Anastasiia | - |
dc.date.accessioned | 2012-12-05T08:19:26Z | - |
dc.date.available | 2012-12-05T08:19:26Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Andreeva A. The adipokin visfatin isulin sensitivity, inflammation regulator in patients with hypertension and obesity / A. Andreeva // 5th International Scientific Interdisciplinary Conference (ISIC) for medical students and young doctors, Kharkiv, April 25–26, 2012 : Abstract book. – Kharkiv, 2012. – P. 49–50. | uk_UK |
dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/2170 | - |
dc.description.abstract | Adipokines play a significant role in the pathogenesis of a lowgrade inflammation associated with obesity, metabolic syndrome and in chronic inflammatory. Visfatin is a novel adipocytokine identified in 2005. On the other hand, visfatin has been suggested to be a beneficial adipokine with insulinmimicking- sensitizing effects, but regulation of visfatin production and its physiological importance in the conditions of obesity and type 2 diabetes mellitus are still not completely understood. | uk_UK |
dc.language.iso | en | uk_UK |
dc.publisher | Kharkiv National Medical University | uk_UK |
dc.subject | visfatin | uk_UK |
dc.subject | insulin sensitivity | uk_UK |
dc.subject | inflammation | uk_UK |
dc.subject | hypertension | uk_UK |
dc.subject | obesity | uk_UK |
dc.title | The adipokin visfatin insulin sensitivity, inflammation regulator in patients with hypertension and obesity | uk_UK |
dc.type | Thesis | uk_UK |
Appears in Collections: | Наукові роботи молодих вчених. Кафедра внутрішньої медицини № 1 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Андреева ISIC.pdf | 4,86 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.